Procurement of medicines for 2026 Biological therapy
Deadline:N/A
Tender information
Extra-Regio level 3
North Makedonia
Type
Contract
Procedure
Unknown
Procurement of medicines for 2026 Biological therapy
L01FG01 Bevacizumab biosimilar 400 mg/16 ml
L01FG01 Bevacizumab biosimilar 400 mg/16 ml
L01EX27 Capivasertib 200mg
L01EX27 Capivasertib 200mg
Buyer
University clinic of radiotherapy and oncology
Documents
Buyer
University clinic of radiotherapy and oncology
No time limit
Important dates
17 Jun - Publication date
Unlock Full Access with Mercell Bidding Business Plus